Timo Kanninen is CTO and co-founder of BC Platforms. He is the visionary behind BC Platforms’ data management systems. He has long-term experience in software development, genetic epidemiology, statistical genetics, and clinical statistics. Mr. Kanninen has also worked with hospital and occupational health IT systems. Mr. Kanninen studied information technology in production and statistics. He is a co-author on 16 scientific articles published in high-level journals.
AI & Data Science Showcase:
BC Platforms is a global leader in providing a powerful data and technology platform and data science services for personalised medicine and drug development, accelerating the translation of insights into clinical practice.
Developing and Validating AI/ML Models for Personalised Medicine
Use of clinical and genome data based AI/ML models for Personalised Medicine has the potential to revolutionise healthcare. To ensure that these models work in different environments and populations, diverse Federated Data Partner Network can be used for model development and validation.
The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.